Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Acrux Limited ( (AU:ACR) ) just unveiled an update.
Acrux Limited has announced the quotation of 8,829,411 options on the Australian Securities Exchange (ASX), set to expire on February 19, 2027. This move is part of previously announced transactions and could enhance the company’s financial flexibility and market presence, potentially impacting stakeholders by increasing investment opportunities.
More about Acrux Limited
Acrux Limited operates in the pharmaceutical industry, focusing on the development and commercialization of topical pharmaceuticals. The company is known for its innovative drug delivery systems and targets both local and international markets.
YTD Price Performance: 33.33%
Average Trading Volume: 1,000
Technical Sentiment Signal: Buy
Current Market Cap: $6.13M
See more data about ACR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue